Aripiprazole versus ziprasidone for schizophrenia

Hong Ling Yang; Jiangang ZHENG; Bin Li; Sai Zhao; Wei Zheng

doi:10.1002/14651858.CD012811

Aripiprazole versus ziprasidone for schizophrenia

Hong Ling Yang^*, Jiangang ZHENG, Bin Li, Sai Zhao, Wei Zheng

^*Corresponding author for this work

School of Chinese Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

Original language	English
Article number	CD012811
Number of pages	13
Journal	Cochrane Database of Systematic Reviews
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD012811
Publication status	Published - 28 Sept 2017

Scopus Subject Areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012811

Cite this

@article{eafe30c65fe149a388c4f8c6333970c8,

title = "Aripiprazole versus ziprasidone for schizophrenia",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.",

author = "Yang, {Hong Ling} and Jiangang ZHENG and Bin Li and Sai Zhao and Wei Zheng",

year = "2017",

month = sep,

day = "28",

doi = "10.1002/14651858.CD012811",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley & Sons Ltd.",

number = "9",

}

TY - JOUR

T1 - Aripiprazole versus ziprasidone for schizophrenia

AU - Yang, Hong Ling

AU - ZHENG, Jiangang

AU - Li, Bin

AU - Zhao, Sai

AU - Zheng, Wei

PY - 2017/9/28

Y1 - 2017/9/28

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=85030110218&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012811

DO - 10.1002/14651858.CD012811

M3 - Article

AN - SCOPUS:85030110218

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD012811

ER -

Aripiprazole versus ziprasidone for schizophrenia

Abstract

Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this